Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Jul;78(7):520–528. doi: 10.1136/bjo.78.7.520

Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.

A D Paridaens 1, A C McCartney 1, D C Minassian 1, J L Hungerford 1
PMCID: PMC504855  PMID: 7522545

Abstract

The role of orbital exenteration in the management of malignant melanoma of the conjunctiva has been underexplored. The outcome in 95 patients with this condition, who underwent exenteration as a primary treatment (n = 36) or after failure of other treatment (n = 59) for early to advanced stages of the disease, was evaluated. The majority of treated cases had multicentric melanomas sited at prognostically unfavourable locations. In the group of tumours with a maximum thickness of 1.0 mm no melanoma related mortality was noted. Melanomas thicker than 1.0 mm were associated with a mortality varying between 33% and 50%, independent of whether exenteration was performed as primary or secondary treatment. An especially poor outcome was noted for the group of caruncular melanomas despite exenteration. These findings indicate that total eradication of tumour should be performed at an early stage. For this purpose, a combination of debulking surgery and adjunctive cryotherapy or beta radiotherapy is more appropriate than orbital exenteration which causes disfigurement and blindness. Exenteration of the orbit should be reserved as a palliative procedure for advanced stages of neoplastic disease.

Full text

PDF
520

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartley G. B., Garrity J. A., Waller R. R., Henderson J. W., Ilstrup D. M. Orbital exenteration at the Mayo Clinic. 1967-1986. Ophthalmology. 1989 Apr;96(4):468–473. doi: 10.1016/s0161-6420(89)32872-7. [DOI] [PubMed] [Google Scholar]
  2. Brownstein S., Jakobiec F. A., Wilkinson R. D., Lombardo J., Jackson W. B. Cryotherapy for precancerous melanosis (atypical melanocytic hyperplasia) of the conjunctiva. Arch Ophthalmol. 1981 Jul;99(7):1224–1231. doi: 10.1001/archopht.1981.03930020098009. [DOI] [PubMed] [Google Scholar]
  3. Folberg R., McLean I. W. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol. 1986 Jul;17(7):652–654. doi: 10.1016/s0046-8177(86)80175-7. [DOI] [PubMed] [Google Scholar]
  4. Folberg R., McLean I. W., Zimmerman L. E. Conjunctival melanosis and melanoma. Ophthalmology. 1984 Jun;91(6):673–678. doi: 10.1016/s0161-6420(84)34245-2. [DOI] [PubMed] [Google Scholar]
  5. Folberg R., McLean I. W., Zimmerman L. E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985 Feb;16(2):136–143. doi: 10.1016/s0046-8177(85)80062-9. [DOI] [PubMed] [Google Scholar]
  6. Folberg R., McLean I. W., Zimmerman L. E. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985 Feb;16(2):129–135. doi: 10.1016/s0046-8177(85)80061-7. [DOI] [PubMed] [Google Scholar]
  7. Fuchs U., Kivelä T., Liesto K., Tarkkanen A. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer. 1989 Feb;59(2):261–267. doi: 10.1038/bjc.1989.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hykin P. G., McCartney A. C., Plowman P. N., Hungerford J. L. Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension. Br J Ophthalmol. 1990 Jan;74(1):36–39. doi: 10.1136/bjo.74.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jakobiec F. A., Brownstein S., Wilkinson R. D., Khalil M., Cooper W. C., Shibata H. R. Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol. 1980 Aug;98(8):1390–1396. doi: 10.1001/archopht.1980.01020040242005. [DOI] [PubMed] [Google Scholar]
  10. Jakobiec F. A. Conjunctival melanoma. Arch Ophthalmol. 1980 Aug;98(8):1378–1384. doi: 10.1001/archopht.1980.01020040230003. [DOI] [PubMed] [Google Scholar]
  11. Jakobiec F. A., Rini F. J., Fraunfelder F. T., Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology. 1988 Aug;95(8):1058–1070. doi: 10.1016/s0161-6420(88)33058-7. [DOI] [PubMed] [Google Scholar]
  12. Kennedy R. E. Indications and surgical techniques for orbital exenteration. Ophthalmology. 1979 May;86(5):967–973. doi: 10.1016/s0161-6420(79)35462-8. [DOI] [PubMed] [Google Scholar]
  13. Kersten R. C., Tse D. T., Anderson R. L., Blodi F. C. The role of orbital exenteration in choroidal melanoma with extrascleral extension. Ophthalmology. 1985 Mar;92(3):436–443. doi: 10.1016/s0161-6420(85)34019-8. [DOI] [PubMed] [Google Scholar]
  14. LEDERMAN M. Radiotherapy of malignant melanomata of the eye. Br J Radiol. 1961 Jan;34:21–42. doi: 10.1259/0007-1285-34-397-21. [DOI] [PubMed] [Google Scholar]
  15. Lommatzsch P. K. Beta irradiation of conjunctival melanomas. Trans Ophthalmol Soc U K. 1977 Sep;97(3):378–380. [PubMed] [Google Scholar]
  16. Lommatzsch P. K., Lommatzsch R. E., Kirsch I., Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990 Oct;74(10):615–619. doi: 10.1136/bjo.74.10.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. NAQUIN H. A. Exenteration of the orbit. AMA Arch Ophthalmol. 1954 Jun;51(6):850–862. doi: 10.1001/archopht.1954.00920040860011. [DOI] [PubMed] [Google Scholar]
  18. Paridaens A. D., McCartney A. C., Hungerford J. L. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol. 1992 Mar;76(3):163–165. doi: 10.1136/bjo.76.3.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Paridaens A. D., McCartney A. C., Lavelle R. J., Hungerford J. L. Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration. Br J Ophthalmol. 1992 Jun;76(6):369–371. doi: 10.1136/bjo.76.6.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. RENDAHL I. Does exenteratio orbitae improve the prognosis in orbital tumour? Acta Ophthalmol (Copenh) 1954;32(4):431–439. doi: 10.1111/j.1755-3768.1954.tb05061.x. [DOI] [PubMed] [Google Scholar]
  21. Rathbun J. E., Beard C., Quickert M. H. Evaluation of 48 cases of orbital exenteration. Am J Ophthalmol. 1971 Jul 30;72(1):191–199. doi: 10.1016/0002-9394(71)91613-8. [DOI] [PubMed] [Google Scholar]
  22. Robertson D. M., Hungerford J. L., McCartney A. Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses. Am J Ophthalmol. 1989 Oct 15;108(4):440–442. doi: 10.1016/s0002-9394(14)73314-8. [DOI] [PubMed] [Google Scholar]
  23. Spaeth E. B. Information learned from fifty years of orbital exenteration. Trans Ophthalmol Soc U K. 1971;91:611–634. [PubMed] [Google Scholar]
  24. Stefani F. H. A prognostic index for patients with malignant melanoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 1986;224(6):580–582. doi: 10.1007/BF02154748. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES